Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03794466 · ClinicalTrials.gov registry record
Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization
A clinical trial of Pelvic Pain and Pelvic Congestive Syndrome, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT03794466: Recruiting study of Pelvic Pain and Pelvic Congestive Syndrome, sponsored by University of Kansas Medical Center.
NCT03794466 is a study of Pelvic Pain and Pelvic Congestive Syndrome that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 30 participants, below the 370-participant average among 23 other Pelvic Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03794466, a study of Pelvic Pain and Pelvic Congestive Syndrome, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.
Primary Outcome
quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils using a survey consisting 4 questions. Answers will be given values 0-4, which higher values are considered to be worse outcomes. One question is "On average, how many days a week do you experience pelvic pain?" Answers would be none (0), 1-2 days a week (1), 3-4 days a week (2), 5-6 days a week (3), and every day of the week (4). Maximum total amount of points will be 16. This is the number of points
Conditions Studied
Study Locations (1)
Kansas
- The University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2027-12-31 |
What NCT03794466 shows while recruiting
NCT03794466 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 370-participant average among 23 other Pelvic Pain trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Pelvic Pain appearing as the primary indexed condition, and to 0 interventions.
NCT03794466 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT03794466 about?
NCT03794466 is a clinical study titled "Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization". The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.
What is the current status of trial NCT03794466?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2019-05-10. Estimated completion is 2027-12-31.
What conditions does trial NCT03794466 study?
This clinical trial studies the following conditions: Pelvic Pain, Pelvic Congestive Syndrome.
Who is sponsoring clinical trial NCT03794466?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03794466 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03794466's enrollment target sits among peer trials
30 19th of 23 higher than 5 of 23 other Pelvic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
-
Endometriosis Pain
RECRUITING
-
NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)
RECRUITING · Phase 4
-
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI